Abstract
THU-224 - Efficacy and safety of Sofosbuvir Plus Daclatasvir bilayer tablet with or without Ribavirin in patients with chronic hepatitis C genotype 4 Infection
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have